# Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker

> **NCT01072058** · PHASE4 · UNKNOWN · sponsor: **University of Sao Paulo** · enrollment: 100 (estimated)

## Conditions studied

- Arthritis, Rheumatoid
- Spondylitis, Ankylosing

## Interventions

- **DRUG:** TNF blockers (infliximab, adalimumab, etanercept)

## Key facts

- **NCT ID:** NCT01072058
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2011-02
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072058, "Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01072058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*